In this study, a higher FABP3 level was independently associated with plasma levels of hs-CRP, visfatin, and WBC count, which suggests that FABP3 may act through inflammatory responses to play an important role in the pathophysiology of reduced EF in patients with stable angina. The gene discussed is FABP3; the disease is angina pectoris.